Arumugam Nallasivan

发表

Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data

C. Gerloff, D. Blacker, C. Anderson, 2020, The Lancet.

Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial

C. Gerloff, T. Neumann-Haefelin, M. Endres, 2020, Neurological Research and Practice.

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, Johshua N. Fletcher, 2019, The Lancet. Neurology.

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, M. Dennis, 2019, Lancet.

Effects of fluoxetine on functional outcomes after acute stroke ( FOCUS ) : a pragmatic , double blind , randomised , controlled

Joshua R. Smith, Ashutosh Kumar Singh, Stephen H. Levy, 2019 .

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, C. Sudlow, 2018, Trials.

Impact of Evidence‐Based Stroke Care on Patient Outcomes: A Multilevel Analysis of an International Study

Sarah S Richtering, Y. Liu, M. Woodward, 2019, Journal of the American Heart Association.

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial

Ashutosh Kumar Singh, Mohammad Irfan Alam, C. Sudlow, 2018, Trials.

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial

C. Sudlow, P. Sandercock, D. Werring, 2018, Trials.